Chemours Co. logo

Chemours Co. (CC)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
12. 74
-0.17
-1.3168%
$
2.05B Market Cap
- P/E Ratio
1% Div Yield
2.2M Volume
- Eps
$ 12.91
Previous Close
Add Transaction
Day Range
12.56 13.16
Year Range
10.44 28.67
Want to track CC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
The Chemours Company (CC) Q4 2024 Earnings Call Transcript

The Chemours Company (CC) Q4 2024 Earnings Call Transcript

The Chemours Company (NYSE:CC ) Q4 2024 Earnings Conference Call February 18, 2025 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - SVP and CFO Conference Call Participants Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Hassan Ahmed - Alembic Global Advisors John McNulty - BMO Vincent Andrews - Morgan Stanley John Roberts - Mizuho Laurence Alexander - Jefferies Jeff Zekauskas - JPMorgan Pete Osterland - Truist Operator Good morning. My name is Michelle, and I will be your conference operator today.

Seekingalpha | 1 year ago
Chemours (CC) Reports Q4 Earnings: What Key Metrics Have to Say

Chemours (CC) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 1 year ago
Chemours (CC) Q4 Earnings Beat Estimates

Chemours (CC) Q4 Earnings Beat Estimates

Chemours (CC) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.31 per share a year ago.

Zacks | 1 year ago
Earnings Preview: Chemours (CC) Q4 Earnings Expected to Decline

Earnings Preview: Chemours (CC) Q4 Earnings Expected to Decline

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Chemours, Tronox And Westlake Will See Earnings Rebound In Chemical Sector Amid TiO2 Recovery And Margin Expansion: Analyst

Chemours, Tronox And Westlake Will See Earnings Rebound In Chemical Sector Amid TiO2 Recovery And Margin Expansion: Analyst

Truist Securities analyst Peter Osterland initiated coverage on several chemicals stocks ahead of earnings release.

Benzinga | 1 year ago
Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 5% Dividend Yields

Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 5% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga | 1 year ago
Chemours and PCC Group Enter Into Chlorine Supply Agreement

Chemours and PCC Group Enter Into Chlorine Supply Agreement

The Chemours Company CC recently announced that the PCC Group intends to build and operate a chlor-alkali facility on the grounds of Chemours' titanium dioxide (TiO2) plant in DeLisle, MS. Chemours and PCC have signed a chlorine supply agreement subject to certain customary conditions.

Zacks | 1 year ago
Chemours (CC) Up 8.8% Since Last Earnings Report: Can It Continue?

Chemours (CC) Up 8.8% Since Last Earnings Report: Can It Continue?

Chemours (CC) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Chemours: Hasn't Been A Great Year, But The Long-Term Prospects Look Bright

Chemours: Hasn't Been A Great Year, But The Long-Term Prospects Look Bright

Chemours Company has underperformed the Russell 2000 and other material stocks in 2024, with negative returns of 36% on a YTD basis. Even though the current quarter is unlikely to be the greatest on account of seasonal issues, we are choosing to be cautiously optimistic on CC now. CC's most profitable division by far -Thermal & Specialized Solutions, is driving topline growth again, as regulatory tailwinds abet the Opteon portfolio.

Seekingalpha | 1 year ago
Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 4% Dividend Yields

Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 4% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga | 1 year ago
Chemours' Earnings and Revenues Surpass Estimates in Q3

Chemours' Earnings and Revenues Surpass Estimates in Q3

CC sees record Q3 sales in the Thermal & Specialized Solutions division, driven by the growth in Opteon refrigerants.

Zacks | 1 year ago
The Chemours Company (CC) Q3 2024 Earnings Call Transcript

The Chemours Company (CC) Q3 2024 Earnings Call Transcript

The Chemours Company (NYSE:CC ) Q3 2024 Earnings Call Transcript November 4, 2024 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - CFO Conference Call Participants Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Mike Leithead - Barclays Vincent Andrews - Morgan Stanley Laurence Alexander - Jefferies John Roberts - Mizuho Hassan Ahmed - Alembic Global Advisors John McNulty - BMO Operator Good morning. My name is Daniel and I will be your conference operator today.

Seekingalpha | 1 year ago
Loading...
Load More